AI Research
Artificial Intelligence in Oncology Market Forecast

Artificial Intelligence in Oncology Market is estimated to be valued at USD 2,145.1 Mn in 2025 and is expected to reach USD 16,382.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 33.7% from 2025 to 2032.
Coherent Market Insights Reports has released a detailed research analysis on the “Artificial Intelligence in Oncology Market 2025”, highlighting key trends, growth dynamics, and forecast insights through 2032. This comprehensive report presents an in-depth evaluation of the market landscape, analyzing the factors that influence industry growth, including manufacturers, suppliers, market participants, and end users. It offers valuable insights into the core drivers fueling market expansion across various segments such as product type, application, end-user, and geographic regions.
The study also captures major strategic developments shaping the industry, including advancements in R&D, mergers and acquisitions, product innovations, strategic alliances, joint ventures, and regional expansions. These elements reflect the competitive positioning of leading market players at both global and regional levels, making this report a valuable resource for stakeholders, investors, and decision-makers seeking a clear understanding of the market’s future trajectory.
Request a sample report (Use Corporate eMail ID to Get Higher Priority) at: https://www.coherentmarketinsights.com/insight/request-sample/6509
Gain Strategic Insights with the Latest Report
The newly released report, paired with an intuitive online dashboard, offers actionable insights to support data-driven decisions. It covers:
• Competitive landscape overview
• Historical data and future forecasts
• Company revenue share analysis
• Regional and national market trends
• Emerging opportunities and growth drivers
The Leading Players involved in the Artificial Intelligence in Oncology Market are:
• Azra AI
• IBM Corporation
• Siemens Healthineers AG
• Intel Corporation
• GE HealthCare
• NVIDIA Corporation
• Digital Diagnostics Inc.
• ConcertAI
• Median Technologies
• PathAI
• Microsoft
• Zebra Medical Vision
• Babylon
Market Segmentation –
This report has explored the key segments: The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2025-2032.
• By Component: Software/Platform, Hardware, Services
• By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others
• By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Others
• By End User: Hospitals & Clinics, Diagnostic Centers, Biopharmaceutical Companies, Others
Get Strategic Insights from the Updated 2025 Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/6509
Research Methodology:
The report has its roots definitely set in thorough strategies provided by proficient data analysts. The research methodology involves the collection of information by analysts only to have them studied and filtered thoroughly in an attempt to provide significant predictions about the market over the review period. The research process further includes interviews with leading market influencers, which makes the primary research relevant and practical. The secondary method gives a direct peek into the demand and supply connection. The market methodologies adopted in the report offer precise data analysis and provide a tour of the entire market. Both primary and secondary approaches to data collection have been used. In addition to these, publicly available sources such as annual reports, and white papers have been used by data analysts for an insightful understanding of the market.
Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.
» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
The Report covers:
✔ Comprehensive research methodology of the Artificial Intelligence in Oncology Market.
✔ This report also includes a detailed and extensive Market overview with key analyst insights.
✔ Exhaustive analysis of macro and micro factors influencing the Market guided by key recommendations.
✔ Analysis of regulations and other government policies impacting the Artificial Intelligence in Oncology Market.
✔ Insights about Market determinants that are stimulating the Artificial Intelligence in Oncology Market.
✔ Detailed and extensive Market segments with regional distribution of forecast revenues.
✔ Extensive profiles and recent developments of Market players.
Reason to Buy:
✅Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Artificial Intelligence in Oncology Market.
✅Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
✅The key findings and recommendations highlight crucial progressive industry trends in the Pet Aquamation Service Market, thereby allowing players to develop effective long-term strategies in order to garner their market revenue.
✅Develop/modify business expansion plans by using substantial growth offerings in developed and emerging markets.
✅Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth to a certain extent.
✅Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.
Buy The Latest Version Of the Reports with an Impressive Discount (Up to 25% Off ) at: https://www.coherentmarketinsights.com/insight/buy-now/6509
1. Which are the key dominating players in the market?
2. What are the key business strategies chosen by the leading player to sustain in the Global Artificial Intelligence in Oncology Market?
3. What are the primary reasons behind the faster market growth rate?
4. Which are the dominating growth factors likely to propel the regional development of the Artificial Intelligence in Oncology industry?
5. What is the expected growth rate of the Global Artificial Intelligence in Oncology Market during the forecast period?
Author of this Marketing PR:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice’s dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837
About CMI:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
This release was published on openPR.
AI Research
The Big Idea: why we should embrace AI doctors | Books

We expect our doctors to be demi-gods – flawless, tireless, always right. But they are only human. Increasingly, they are stretched thin, working long hours, under immense pressure, and often with limited resources. Of course, better conditions would help, including more staff and improved systems. But even in the best-funded clinics with the most committed professionals, standards can still fall short; doctors, like the rest of us, are working with stone age minds. Despite years of training, human brains are not optimally equipped for the pace, pressure, and complexity of modern healthcare.
Given that patient care is medicine’s core purpose, the question is who, or what, is best placed to deliver it? AI may still spark suspicion, but research increasingly shows how it could help fix some of the most persistent problems and overlooked failures – from misdiagnosis and error to unequal access to care.
As patients, each of us will face at least one diagnostic error in our lifetimes. In England, conservative estimates suggest that about 5% of primary care visits result in a failure to properly diagnose, putting millions of patients in danger. In the US, diagnostic errors cause death or permanent injury to almost 800,000 people annually. Misdiagnosis is a greater risk if you’re among the one in 10 people worldwide with a rare disease.
Modern medicine prides itself on being scientific, yet doctors don’t always practise what the evidence recommends. Studies show that evidence-based treatments are offered only about half the time to adults in the US. Doctors can also disagree about diagnoses. In a study of more than 12,000 radiology images, reviewers offering second opinions disagreed with the original assessment in about one in three cases – leading to a change in treatment nearly 20% of the time. As the work day wears on, quality slips further: inappropriate antibiotic prescriptions rise, while cancer screening rates fall.
As alarming as this is, there are understandable reasons for these failures – and viewed from another angle, it’s remarkable that doctors get it right as often as they do. The realities of being human – distraction, multitasking, even our body clocks – take a toll. But burnout, depression and cognitive ageing don’t just wear doctors down; they raise the risk of clinical mistakes.
Medical knowledge also moves faster than doctors can keep up. By graduation, half of what medical students learn is already outdated. It takes an average of 17 years for research to reach clinical practice, and with a new biomedical article published every 39 seconds, even skimming the abstracts would take about 22 hours a day. There are more than 7,000 rare diseases, with 250 more identified each year.
In contrast, AI devours medical data at lightning speed, 24/7, with no sleep and no bathroom breaks. Where doctors vary in unwanted ways, AI is consistent. And while these tools make errors too, it would be churlish to deny how impressive the latest models are, with some studies showing they vastly outperform human doctors in clinical reasoning, including for complex medical conditions.
AI’s superpower is spotting patterns humans miss, and these tools are surprisingly good at recognising rare diseases – often better than doctors. For example, in one 2023 study researchers fed 50 clinical cases – including 10 rare conditions – into ChatGPT-4. It was asked to provide diagnoses in the form of ranked suggestions. It solved all of the common cases by the second suggestion, and got 90% of the rare conditions by the eighth – outperforming the human doctors used as comparators. Patients and their families are increasingly recognising these benefits. One child, Alex, saw 17 doctors over three years for chronic pain – none could explain his symptoms. Desperate, his mother turned to ChatGPT, which suggested a rare condition called tethered cord syndrome. Doctors confirmed the diagnosis, and Alex is now receiving proper treatment.
Then there’s the problem of access. Healthcare is upside down. Those most in need – the sickest, poorest, and most marginalised in society – are the ones most likely to be left behind. Packed schedules and poor public transport mean millions miss appointments. Parents and part-time workers, including those with gig economy jobs, often struggle to attend checkups. American Time Use Survey data shows patients sacrifice two hours for a 20-minute doctor’s visit. The problems are often worse for people with disabilities, who are about four times more likely to miss out on care in the UK due to issues with transport, costs and long waiting lists. Compared with men with no disability, disabled women are more than seven times more likely to have unmet needs due to the cost of care or medication.
And yet we rarely question the idea of waiting in line at the doctor’s office in town because it’s simply the way things have always been done. AI could change that. Imagine a doctor in your pocket offering information when and where you need it. Under Labour’s 10-year plan, Wes Streeting, the health secretary, has announced that patients will soon be able to discuss their health concerns with AI via the NHS app. It’s a bold step – and one that could bring quicker, actionable clinical advice for millions.
This will only work for those who can use it, of course. Internet access is improving globally, but there are still serious gaps: 2.5 billion people remain offline. In the UK, 8.5 million people lack basic digital skills, and 3.7 million families fall below the “minimum digital living standard”, meaning they have poor connectivity, outdated devices and limited support. Confidence is a barrier too: 21% of people in the UK say they feel left behind by technology.
At the moment, AI healthcare research almost exclusively fixates on its flaws. Examining the technology’s potential for bias and errors is a crucially important task. But this orientation doesn’t take account of the creaking and sometimes unsafe systems we already rely on. Any fair assessment of AI must be weighed against the realities of what we’ve currently got – a system that too often can be frustrating, out of reach, or just plain wrong.
Charlotte Blease is a health researcher and the author of Dr Bot: Why Doctors Can Fail Us – and How AI Could Save Lives, published by Yale on 9 September.
Further reading
Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again by Eric Topol (Basic Books, £28)
Co-Intelligence: Living and Working with AI by Ethan Mollick (WH Allen, £16.99)
Artificial Intelligence: A Guide for Thinking Humans by Melanie Mitchell (Pelican, £10.99)
AI Research
Billionaire Philipe Laffont Just Sold Coatue Management’s Stake in Super Micro Computer and Piled Into Another Artificial Intelligence (AI) Giant Up Over 336,000% Since Its IPO

Philipe Laffont is part of an elite group of investors called the Tiger Cubs, who worked for Julian Robertson’s Tiger Management in the 1990s.
In the 1990s, an elite group of investors worked for a tech-focused hedge fund called Tiger Management, led by the legendary investor Julian Robertson. Not only did Robertson mentor this group of investors, but he would go on to seed many of their future hedge funds as the talented group, referred to as the Tiger Cubs, went on to become great investors in their own right.
Philippe Laffont, the founder of Coatue Management, is part of this group, and is now viewed as one of the great tech investors of the modern era. Coatue Management’s equity holdings were valued at roughly $35 billion at the end of the second quarter. That’s why investors are always paying attention to which stocks Coatue is buying and selling.
In the second quarter, the fund sold its stake in Super Micro Computer (SMCI -5.42%) and piled into another artificial intelligence (AI) giant that generated a total return over 336,000% since its initial public offering.
Image source: Getty Images.
Super Micro Computer: Beating the shorts so far
AI and tech infrastructure and server maker Super Micro Computer has been a controversial and volatile play for the past year. In August 2024, short-seller Hindenburg Research came out with a major short report alleging potential accounting fraud at the company. The report said that Supermicro rehired executives who had been a part of an accounting scandal at the company in 2018 that involved understating expenses and overstating revenue.
The stock got hit hard after Supermicro announced it would need to delay its annual 2024 filing to assess its internal controls. However, the company would eventually go on to file its 2024 10-K and did not need to restate any of its financial statements, a good sign for investors. Furthermore, management earlier this year also provided strong fiscal 2026 guidance of $40 billion in revenue, way ahead of consensus at the time. Supermicro’s fiscal year ends on June 30 of each year.
In August, shares struggled after the company reported lower-than-expected quarterly results and weaker-than-expected guidance, due to President Donald Trump’s tariffs, which resulted in less working capital in June and “specification changes from a major new customer.” Laffont and Coatue loaded up on the stock some time in the fourth quarter of 2024 and sold in the second quarter of this year, so the fund could have bought the dip after the short report and might have sold over concerns about tariffs, although that’s speculation. Supermicro’s stock is up about 46% this year, so Coatue seems to have timed its trade well.
Supermicro looks real cheap right now for a stock benefiting from the AI boom, trading around 16 times forward earnings. Tariffs are likely to be an ongoing issue but if AI demand remains strong, Supermicro, which supplies servers to the likes of Nvidia, should be a major beneficiary. The stock may remain volatile, but I think investors can take a position in the more speculative part of their portfolio.
Oracle: A longtime tech player benefiting from AI
With a market cap of nearly $664 billion, Oracle (ORCL -5.97%) isn’t part of the “Magnificent Seven,” but it’s another large tech company expected to benefit from the AI capital expenditure boom. Coatue purchased over 3.8 million shares in the second quarter, valued at over $843 million.
The cloud giant offers clients the ability to tap into a number of AI solutions including generative AI and machine learning capabilities that provide automation tools and AI application development, among other services. Similar to Microsoft and Amazon, although not as dominant, Oracle’s position as a cloud provider positions the company well to be a first point of contact for clients looking to add AI capabilities.
In the company’s most recent earnings report for its fourth quarter of fiscal 2025, which ended May 31, Oracle reported results ahead of Wall Street estimates and said that cloud infrastructure revenue sales should increase 70% in fiscal year 2026, after generating 52% growth in fiscal 2025.
Oracle CEO Larry Ellison said the company is particularly well positioned because it has a strong data advantage and has developed one of the most comprehensive databases in the world. “Our applications take all of your application data and make that data available to the most popular AI models,” he said on Oracle’s earnings call for the company’s fiscal fourth quarter of 2025.
If you like ChatGPT, you use ChatGPT. If you like Grok, you use Grok. You use that in the Oracle Cloud. We are the key enabler for enterprises to use their own data and models. No one else is doing that.
Having gone public in 1986, Oracle has been a major tech disruptor for decades. The stock is up over 336,000% since its initial public offering and also up over 41% this year. Trading at 34 times forward earnings, the stock is not necessarily cheap, but given its track record and strong expected growth in cloud infrastructure, Oracle can benefit from AI without being as much in the spotlight as some of the Magnificent Seven names.
Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Microsoft, Nvidia, and Oracle. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
AI Research
TikTok Salaries Revealed: How Much AI, E-Commerce Workers Make in 2025

TikTok’s US plans are up in the air due to a divest-or-ban law that puts its future in jeopardy. But it’s still offering six-figure salaries to workers this year in key areas like e-commerce and artificial intelligence.
It’s sought to hire data scientists to sharpen its search algorithm, court workers to grow its e-commerce platform TikTok Shop, and bring in machine learning engineers to improve its content feed and recommendations.
The company’s jobs portal lists over 1,800 open roles in the US in cities like Austin, San Jose, Seattle, and New York.
Like other Big Tech firms, work expectations at TikTok and its owner, ByteDance, are demanding. The company runs performance reviews twice a year, and low scorers can be placed on performance-improvement plans or even shown the door. But the opportunity to work at one of the most influential tech companies in the world continues to draw in talent.
Outside e-commerce, TikTok is shaking up areas like music marketing and young people’s news habits. If it can navigate political tides in the US and China, where ByteDance was founded, it will stand alongside YouTube and a few other players in shaping the next phase of media.
“From a career growth standpoint, you have access to huge budgets and big names,” a former staffer said of working at TikTok. “Everyone in the industry wants to talk to you.”
While TikTok and ByteDance don’t disclose salary information publicly (unless required by state law), they do submit pay ranges in federal filings when they look to hire workers from outside the US.
To understand more about the company’s pay rates, Business Insider reviewed thousands of TikTok salary offers for foreign hires at the company, as well as its owner, ByteDance, for the first three quarters of this reporting year that ran through June 30. The results don’t include equity or other benefits that employees often receive in addition to base pay. But they paint a picture of the range of pay a worker might expect in roles like software engineering, data science, or product management.
The foreign-hire data shows a wide range of salaries at the companies. For example, a finance representative could earn $65,000 a year, and a global head of product and design position could fetch a $949,349 annual salary.
Backend software engineers at TikTok could earn between $144,000 and $301,158, based on the salary data, though rates increased beyond that for specialties like trust and safety. Data scientist positions at TikTok were generally offered between $85,821 and $283,629 — or more in specific areas like e-commerce. For TikTok machine learning scientists, the range was between $168,000 and $390,000, while general marketing managers were offered between $85,000 and $430,000.
These salary offers fall in line with pay rates in federal applications at other Big Tech firms. Meta’s first-quarter visa filings revealed it offered data scientists between $122,760 and $270,000, for example. Meanwhile, a staff software engineer at Google could receive between $220,000 and $323,000, according to the company’s first-quarter filings.
Here are the salary ranges TikTok and ByteDance offered for other roles in key business areas, based on recent applications. TikTok and ByteDance did not respond to requests for comment.
E-commerce and TikTok Shop roles
TikTok Shop – Celebrity Team Live Operation Manager: $94,000
TikTok Shop – US Data Analyst – Logistics: $128,000
TikTok Shop – Campaign Strategy Operations Manager: $132,000
TikTok Shop – Category Manager – Health: $135,000
TikTok Shop – Anti-Fraud Ops Program Mgr – Global Selling: $180,000
TikTok Shop – Data Scientist: $218,000 to $304,000
Product Manager, User Growth Customer Lifecycle-TikTok Shop: $220,000
Strategy Manager, E-Commerce: $228,000 to $230,000
Software Engineer – E-commerce Recommendation Infrastructure: $237,000 to $315,207
TikTok Shop – Inventory Placement Strategy Manager: $250,000
TikTok Shop- Compliance Operation: $257,600
Senior Machine Learning Engineer, E-commerce: $320,000
Tech Lead – E-commerce Recommendation Infrastructure: $320,113
Logistics Procurement Lead, TikTok US E-commerce: $350,000
Senior Data Scientist, Content E-commerce: $350,000
Tech Lead, Global E-commerce Governance Platform: $365,000
Global E-commerce Solutions Manager: $480,000
AI and machine learning roles
Software Engineer (AI Platform): $144,000
Research Scientist (TikTok AI Privacy): $188,000
Product Manager GenAI Safety, Trust & Safety: $218,400
Senior Product Designer, Creation (AI Projects): $221,368
Machine Learning Engineer – Computer Vision: $228,960
Software Engineer, Machine Learning Infrastructure: $270,000 to $320,783
Site Reliability Engineer, AI Applications: $276,000
AI Product Manager: $300,010
Product Manager Lead, Emerging Product & AI Safety: $336,000
AI Security Researcher – Security Flow: $340,000
Senior Machine Learning Engineer, TikTok Recommendation: $386,115
Search roles
Search Product Operations – Creator Search Optimization: $110,000
Software Engineer – TikTok Search Business Infrastructure: $154,880 to $214,720
Product Manager, Search Ads: $205,000
Machine Learning Engineer – Search Ads: $229,200 to $354,000
Machine Learning Engineer – TikTok Search: $241,200 to $300,000
Senior Machine Learning Engineer – TikTok Search Business: $268,920
Product Manager – TikTok Search: $287,500
Product Manager, Search Content Ecosystem: $400,000
Leader of Search and Recommendation Product (ByteDance): $540,552
Search Ads Closed-loop Product Manager: $564,000
-
Tools & Platforms3 weeks ago
Building Trust in Military AI Starts with Opening the Black Box – War on the Rocks
-
Ethics & Policy1 month ago
SDAIA Supports Saudi Arabia’s Leadership in Shaping Global AI Ethics, Policy, and Research – وكالة الأنباء السعودية
-
Business2 days ago
The Guardian view on Trump and the Fed: independence is no substitute for accountability | Editorial
-
Events & Conferences3 months ago
Journey to 1000 models: Scaling Instagram’s recommendation system
-
Jobs & Careers2 months ago
Mumbai-based Perplexity Alternative Has 60k+ Users Without Funding
-
Funding & Business2 months ago
Kayak and Expedia race to build AI travel agents that turn social posts into itineraries
-
Education2 months ago
VEX Robotics launches AI-powered classroom robotics system
-
Podcasts & Talks2 months ago
Happy 4th of July! 🎆 Made with Veo 3 in Gemini
-
Podcasts & Talks2 months ago
OpenAI 🤝 @teamganassi
-
Mergers & Acquisitions2 months ago
Donald Trump suggests US government review subsidies to Elon Musk’s companies